GB2201676B - Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it - Google Patents
Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing itInfo
- Publication number
- GB2201676B GB2201676B GB8803438A GB8803438A GB2201676B GB 2201676 B GB2201676 B GB 2201676B GB 8803438 A GB8803438 A GB 8803438A GB 8803438 A GB8803438 A GB 8803438A GB 2201676 B GB2201676 B GB 2201676B
- Authority
- GB
- United Kingdom
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- piperazinecarboxylic acid
- piperazinecarboxylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878703749A GB8703749D0 (en) | 1987-02-18 | 1987-02-18 | Piperazinecarboxylic acid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8803438D0 GB8803438D0 (en) | 1988-03-16 |
| GB2201676A GB2201676A (en) | 1988-09-07 |
| GB2201676B true GB2201676B (en) | 1991-01-02 |
Family
ID=10612501
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB878703749A Pending GB8703749D0 (en) | 1987-02-18 | 1987-02-18 | Piperazinecarboxylic acid |
| GB8803438A Expired - Lifetime GB2201676B (en) | 1987-02-18 | 1988-02-15 | Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB878703749A Pending GB8703749D0 (en) | 1987-02-18 | 1987-02-18 | Piperazinecarboxylic acid |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPH0723387B2 (en) |
| KR (1) | KR960015190B1 (en) |
| AT (1) | AT391320B (en) |
| AU (1) | AU613009B2 (en) |
| BE (1) | BE1002427A3 (en) |
| CA (1) | CA1327799C (en) |
| CH (1) | CH675125A5 (en) |
| CY (1) | CY1739A (en) |
| DE (1) | DE3804936C2 (en) |
| DK (1) | DK168441B1 (en) |
| ES (2) | ES2011319A6 (en) |
| FI (1) | FI86733C (en) |
| FR (1) | FR2610932B1 (en) |
| GB (2) | GB8703749D0 (en) |
| GR (1) | GR1002471B (en) |
| HK (1) | HK142093A (en) |
| HU (2) | HU199858B (en) |
| IE (1) | IE59098B1 (en) |
| IL (1) | IL85436A0 (en) |
| IT (1) | IT1219447B (en) |
| LU (1) | LU87129A1 (en) |
| MY (1) | MY103206A (en) |
| NL (1) | NL8800412A (en) |
| NZ (1) | NZ223529A (en) |
| PH (1) | PH25512A (en) |
| PT (1) | PT86776B (en) |
| SE (1) | SE467256B (en) |
| ZA (1) | ZA881146B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12318358B2 (en) | 2017-07-13 | 2025-06-03 | Paris Sciences Et Lettres | Probenecid for use in treating epileptic diseases, disorders or conditions |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU202111B (en) * | 1988-03-11 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component |
| US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| EP0488959A3 (en) * | 1990-11-28 | 1992-08-05 | Sandoz Ltd. | New uses of competitive nmda receptor antagonists |
| US5260286A (en) * | 1992-10-16 | 1993-11-09 | Japan Tobacco, Inc. | 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists |
| AU5693996A (en) * | 1995-05-08 | 1996-11-29 | Lonza A.G. | Biotechnical production process of piperazine r-alpha-carbox ylic acids and piperazine s-alpha-carboxylic acid amide |
| JP4189867B2 (en) | 1997-05-12 | 2008-12-03 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | Aryl-substituted piperazines useful in the treatment of benign prostatic hyperplasia |
| GB9821179D0 (en) * | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
| JP2008124531A (en) | 2006-11-08 | 2008-05-29 | Nec Electronics Corp | Semiconductor device and audio processor chip |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2157685A (en) * | 1984-04-17 | 1985-10-30 | Nat Res Dev | Piperazine derivatives |
-
1987
- 1987-02-18 GB GB878703749A patent/GB8703749D0/en active Pending
-
1988
- 1988-02-11 LU LU87129A patent/LU87129A1/en unknown
- 1988-02-12 BE BE8800177A patent/BE1002427A3/en active
- 1988-02-12 FR FR888801782A patent/FR2610932B1/en not_active Expired - Lifetime
- 1988-02-12 IT IT47631/88A patent/IT1219447B/en active
- 1988-02-15 MY MYPI88000155A patent/MY103206A/en unknown
- 1988-02-15 GB GB8803438A patent/GB2201676B/en not_active Expired - Lifetime
- 1988-02-16 HU HU88746A patent/HU199858B/en not_active IP Right Cessation
- 1988-02-16 IL IL85436A patent/IL85436A0/en not_active IP Right Cessation
- 1988-02-16 IE IE41388A patent/IE59098B1/en not_active IP Right Cessation
- 1988-02-16 PH PH36514A patent/PH25512A/en unknown
- 1988-02-16 DK DK079688A patent/DK168441B1/en not_active IP Right Cessation
- 1988-02-16 NZ NZ223529A patent/NZ223529A/en unknown
- 1988-02-16 GR GR880100084A patent/GR1002471B/en not_active IP Right Cessation
- 1988-02-16 CH CH549/88A patent/CH675125A5/de not_active IP Right Cessation
- 1988-02-16 AU AU11758/88A patent/AU613009B2/en not_active Ceased
- 1988-02-16 CA CA000559170A patent/CA1327799C/en not_active Expired - Fee Related
- 1988-02-17 PT PT86776A patent/PT86776B/en not_active IP Right Cessation
- 1988-02-17 JP JP63036458A patent/JPH0723387B2/en not_active Expired - Lifetime
- 1988-02-17 AT AT0036788A patent/AT391320B/en not_active IP Right Cessation
- 1988-02-17 FI FI880744A patent/FI86733C/en not_active IP Right Cessation
- 1988-02-17 SE SE8800541A patent/SE467256B/en not_active IP Right Cessation
- 1988-02-17 KR KR1019880001680A patent/KR960015190B1/en not_active Expired - Fee Related
- 1988-02-17 DE DE3804936A patent/DE3804936C2/en not_active Expired - Fee Related
- 1988-02-18 ZA ZA881146A patent/ZA881146B/en unknown
- 1988-02-18 NL NL8800412A patent/NL8800412A/en not_active Application Discontinuation
- 1988-02-18 ES ES888800466A patent/ES2011319A6/en not_active Expired - Lifetime
-
1989
- 1989-10-16 ES ES8903482A patent/ES2021904A6/en not_active Expired - Lifetime
-
1993
- 1993-12-30 HK HK1420/93A patent/HK142093A/en not_active IP Right Cessation
-
1995
- 1995-06-09 HU HU95P/P00176P patent/HU211269A9/en unknown
- 1995-10-20 CY CY173995A patent/CY1739A/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2157685A (en) * | 1984-04-17 | 1985-10-30 | Nat Res Dev | Piperazine derivatives |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12318358B2 (en) | 2017-07-13 | 2025-06-03 | Paris Sciences Et Lettres | Probenecid for use in treating epileptic diseases, disorders or conditions |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL76453A (en) | Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL84723A0 (en) | Substituted basic 2-amino-tetralins,their preparation and pharmaceutical compositions containing them | |
| IL81322A0 (en) | Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them | |
| IL84302A (en) | Substituted :-aminoacids, their preparation and pharmaceutical compositions containing them | |
| IL84060A0 (en) | Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them | |
| IL78942A0 (en) | Thiazolidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL87644A0 (en) | Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them | |
| IL85969A0 (en) | Ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
| IL83049A (en) | 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
| IL84808A (en) | Furanuronic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| GB2201676B (en) | Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it | |
| IL81165A0 (en) | Aminoglycoside nor-cholanic acid lactams,their preparation and pharmaceutical compositions containing them | |
| IL88237A0 (en) | Fluoromethoxyphenyl dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| IL86478A0 (en) | Substituted vinylcephalosporins,their preparation and pharmaceutical compositions containing them | |
| IL86926A0 (en) | 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them | |
| IL87130A0 (en) | Hydrocinnamic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
| IL75913A (en) | Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL85612A0 (en) | 4-phenylpiperidine compounds,their preparation and pharmaceutical compositions containing them | |
| IL75775A0 (en) | Aminoeburnanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL88743A0 (en) | Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it | |
| IL85824A0 (en) | Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them | |
| GB2206115B (en) | 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| IL88673A0 (en) | N-hydroxy-5-phenyl-2-furancarboxi-midamides,and pharmaceutical compositions containing them | |
| IL84633A0 (en) | 1-aryloxy-3-amino-2-propanols,their preparation and pharmaceutical compositions containing them | |
| IL75776A (en) | Nitroapovincaminic acid derivatives,their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |